TERMIN-
kalkulator
RIETELLER

Oppgi første dag i siste menstruasjon

Beregnet termin  
Svangerskapsuke  
Tid til fødsel  
Befruktningsdato  
Start Slutt Varighet Hyppighet

Utgave for helsepersonell

katt

Det viktigste reservoar for parasitten er katter.

Parasitten Toxoplasma gondii finnes over hele verden. Mange mennesker har vært smittet, de fleste uten å vite om det.

  • Sist endret: 13.11.2014
  • Sist revidert: 13.11.2014

Vil du vite mer?

  • Toksoplasmose - for helsepersonell

Quiz

  • Har du fått med deg det viktigste i dette dokumentet? Da utfordrer vi deg til å ta vår quiz om toksoplasmose!

Dette dokumentet er basert på det profesjonelle dokumentet "Toksoplasmose" i Norsk Elektronisk Legehåndbok. Referanselisten for dette dokumentet vises nedenfor.

Referanser

  1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76. PubMed
  2. Boyer K, Hill D, Mui E, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis 2011; 53: 1081-9. PubMed
  3. Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 1998, 120, 87-92.
  4. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild, Eng J. Incidence of Toxoplasma gondii infection in 35,949 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998, 36, 2900-6.
  5. Cook AJC, Gilbert RE, Buffolano W, Zuffery J, Petersen E, Jenum PA,  Foulon W, Semprini AE, Dunn DT. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 2000; 321:142-7. BMJ
  6. Kapperud G, Jenum PA, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Risk factors for Toxoplasma gondii infection in pregnancy. Am J Epidemiol 1996, 144, 405-12.
  7. Blystad H. Toksoplasmose - veileder for helsepersonell. Smittevernveilederen. Folkehelseinstituttet 2014.
  8. Jenum PA, Stray-Pedersen, Gundersen A-G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997, 35, 1972-7.
  9. Jenum PA, Stray-Pedersen B. Development of specific immunoglobulins G, M and A following primary Toxoplasma gondii infection in pregnant women. J Clin Micobiol 1998, 36, 2907-13.
  10. Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. Acta Pathol Microbiol Immunol Scand 1998, 106, 680-6.
  11. Stray-Pedersen B, Jenum PA. Toksoplasmose og graviditet. Tidsskr Nor Lægeforen 1994, 114, 1823-6.
  12. Foulon W, Villena I, Stray-Pedersen PA, Decoster A, Lappalainen M, Pinon J-M, Jenum PA, Hedman K, Naessens A. Treatment of toxoplasmosis during pregnancy: inpact on fetal transmission and children's sequelae at one year of age: a multicenter study. Am J Obstet Gynecol 1999 180, 410-5
  13. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis during pregnancy. Oxford: The Cochrane Library, issue 3, 1999. Last amendment: 10 May 1999. Cochrane
  14. Gilbert RE, See SE, Jones LV, Stanford MS. Antibiotics versus control for toxoplasma retinochoroiditis (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software. Cochrane
  15. Stray-Pedersen B, Jenum P. Economic avaluation of preventive programmes against toxoplasmosis. Scand J Infect Dis 1992, Suppl 84, 86-96.
  16. Forebygging av medfødt toksoplasmose i Norge. Rapport. Statens institutt for folkehelse, Oslo, Januar 1996.
  17. Eskild A, Oxman A, Magnus P, Bjørndal A, Bakketeig L. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen 1996, 3, 188-94.
  18. Berrebi A, Assouline C, Bessieres MH, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 2010; 203: 552. PubMed
  19. Remington JS, Desmonts G. Toxoplasmosis. In Infectious diseases of the fetus and the newborn infant. (Ed J.S.Remington and J.O.Klein), W. B. Saunders Philadelphia 1990; 89-195.
  20. Eyles DE, Coleman N. An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis. Antibiot Chemother 1955, 5, 529-39.
  21. Schoondermark EV, Galama J, Vree T, Camps W, Baars I, Eskes T, Meuwissen J, Melchers W. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine. Antimicrob Agent Chemother 1995, 39, 137-44.
  22. Leport C, Raffi F, Matheron S et al. Treatment of central nervous system toxoplasmosis with pyrimethamin sulfadiazine in 35 patients with the acquired immunodeficiency syndrome.  Am J Med 1989, 86, 94-100.
  23. Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, Sharples LD, Wallwork J. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart-lung transplant patients. Transplant Int 1992, 5, 197-200.
  24. Olliaro P. Congenital toxoplasmosis. Clin Evid 2001; 6: 528-31. ClinEvid

Debattregler